Securian Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.08M | Hold |
6,899
| – | – | 0.12% | 111 |
|
|
2025
Q4 | $3.13M | Sell |
6,899
-5,417
| -44% | -$2.33M | 0.12% | 114 |
|
|
2025
Q3 | $4.82M | Sell |
12,316
-1,126
| -8% | -$471K | 0.13% | 123 |
|
|
2025
Q2 | $5.98M | Sell |
13,442
-156
| -1% | -$71.9K | 0.17% | 107 |
|
|
2025
Q1 | $6.59M | Sell |
13,598
-211
| -2% | -$98.3K | 0.2% | 98 |
|
|
2024
Q4 | $5.56M | Sell |
13,809
-435
| -3% | -$202K | 0.16% | 107 |
|
|
2024
Q3 | $6.62M | Sell |
14,244
-551
| -4% | -$265K | 0.19% | 91 |
|
|
2024
Q2 | $6.93M | Sell |
14,795
-384
| -3% | -$167K | 0.2% | 92 |
|
|
2024
Q1 | $6.34M | Sell |
15,179
-1,145
| -7% | -$484K | 0.19% | 100 |
|
|
2023
Q4 | $6.64M | Sell |
16,324
-2,177
| -12% | -$804K | 0.19% | 94 |
|
|
2023
Q3 | $6.43M | Sell |
18,501
-3,131
| -14% | -$1.1M | 0.19% | 100 |
|
|
2023
Q2 | $7.61M | Sell |
21,632
-270
| -1% | -$91K | 0.2% | 101 |
|
|
2023
Q1 | $6.9M | Buy |
21,902
+168
| +0.8% | +$50.4K | 0.18% | 109 |
|
|
2022
Q4 | $6.28M | Buy |
21,734
+216
| +1% | +$65.8K | 0.18% | 117 |
|
|
2022
Q3 | $6.23M | Buy |
21,518
+228
| +1% | +$65.6K | 0.19% | 100 |
|
|
2022
Q2 | $6M | Hold |
21,290
| – | – | 0.14% | 152 |
|
|
2022
Q1 | $5.56M | Sell |
21,290
-233
| -1% | -$55.3K | 0.11% | 186 |
|
|
2021
Q4 | $4.73M | Sell |
21,523
-891
| -4% | -$173K | 0.09% | 218 |
|
|
2021
Q3 | $4.07M | Sell |
22,414
-205
| -0.9% | -$40K | 0.08% | 224 |
|
|
2021
Q2 | $4.56M | Sell |
22,619
-267
| -1% | -$55.8K | 0.09% | 212 |
|
|
2021
Q1 | $4.92M | Sell |
22,886
-782
| -3% | -$172K | 0.11% | 196 |
|
|
2020
Q4 | $5.59M | Sell |
23,668
-414
| -2% | -$95K | 0.13% | 179 |
|
|
2020
Q3 | $6.55M | Sell |
24,082
-412
| -2% | -$114K | 0.16% | 139 |
|
|
2020
Q2 | $7.11M | Sell |
24,494
-1,167
| -5% | -$316K | 0.18% | 128 |
|
|
2020
Q1 | $6.11M | Sell |
25,661
-409
| -2% | -$93.8K | 0.17% | 136 |
|
|
2019
Q4 | $5.71M | Sell |
26,070
-812
| -3% | -$164K | 0.13% | 178 |
|
|
2019
Q3 | $4.55M | Sell |
26,882
-140
| -0.5% | -$24.8K | 0.1% | 208 |
|
|
2019
Q2 | $4.96M | Buy |
27,022
+336
| +1% | +$58.7K | 0.11% | 182 |
|
|
2019
Q1 | $4.91M | Buy |
26,686
+164
| +0.6% | +$30.3K | 0.12% | 179 |
|
|
2018
Q4 | $4.39M | Buy |
26,522
+173
| +0.7% | +$30K | 0.12% | 176 |
|
|
2018
Q3 | $5.08M | Buy |
26,349
+65
| +0.2% | +$11.6K | 0.12% | 176 |
|
|
2018
Q2 | $4.47M | Buy |
26,284
+164
| +0.6% | +$25.4K | 0.11% | 196 |
|
|
2018
Q1 | $4.26M | Buy |
26,120
+200
| +0.8% | +$32.7K | 0.11% | 195 |
|
|
2017
Q4 | $3.88M | Buy |
25,920
+365
| +1% | +$54K | 0.1% | 214 |
|
|
2017
Q3 | $3.88M | Buy |
25,555
+369
| +1% | +$55.5K | 0.1% | 208 |
|
|
2017
Q2 | $3.25M | Buy |
25,186
+257
| +1% | +$30.9K | 0.09% | 236 |
|
|
2017
Q1 | $2.73M | Buy |
24,929
+44
| +0.2% | +$3.87K | 0.07% | 261 |
|
|
2016
Q4 | $1.83M | Buy |
24,885
+352
| +1% | +$28.6K | 0.05% | 342 |
|
|
2016
Q3 | $2.14M | Buy |
24,533
+357
| +1% | +$33.7K | 0.06% | 304 |
|
|
2016
Q2 | $2.08M | Buy |
24,176
+214
| +0.9% | +$18.5K | 0.06% | 298 |
|
|
2016
Q1 | $1.91M | Buy |
23,962
+291
| +1% | +$26.3K | 0.05% | 318 |
|
|
2015
Q4 | $2.98M | Buy |
23,671
+627
| +3% | +$75.7K | 0.09% | 221 |
|
|
2015
Q3 | $2.4M | Sell |
23,044
-92
| -0.4% | -$11.8K | 0.08% | 238 |
|
|
2015
Q2 | $2.86M | Buy |
23,136
+480
| +2% | +$60.5K | 0.09% | 232 |
|
|
2015
Q1 | $2.67M | Buy |
22,656
+819
| +4% | +$98.1K | 0.08% | 250 |
|
|
2014
Q4 | $2.59M | Buy |
21,837
+855
| +4% | +$96.3K | 0.08% | 239 |
|
|
2014
Q3 | $2.36M | Buy |
20,982
+9
| +0% | +$857 | 0.08% | 249 |
|
|
2014
Q2 | $1.99M | Buy |
20,973
+58
| +0.3% | +$4.07K | 0.07% | 274 |
|
|
2014
Q1 | $1.48M | Buy |
20,915
+174
| +0.8% | +$13.8K | 0.05% | 314 |
|
|
2013
Q4 | $1.54M | Buy |
20,741
+131
| +0.6% | +$9.12K | 0.06% | 307 |
|
|
2013
Q3 | $1.56M | Sell |
20,610
-12,565
| -38% | -$1,000K | 0.06% | 290 |
|
|
2013
Q2 | $2.65M | Buy |
+33,175
| New | +$2.44M | 0.11% | 198 |
|
Other funds holding VRTX
VCM
VPM
Securian Asset Management's VRTX Position: Q1 2026 in Review
Securian Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 6,899 shares worth $3.08M. The position accounts for 0.12% of the portfolio, ranked #111.
Securian Asset Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.61M in Q2 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Securian Asset Management held 6,899 shares of Vertex Pharmaceuticals worth $3.08M as of Q1 2026.
- Securian Asset Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
- Vertex Pharmaceuticals made up 0.12% of Securian Asset Management's portfolio in Q1 2026, its #111 holding.
- Securian Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Securian Asset Management's Vertex Pharmaceuticals position peaked at $7.61M in Q2 2023.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Securian Asset Management's 13F filing for Q1 2026, filed 1 May 2026.